13F-HR filed by RP Management, LLC
RP Management, LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-13, with 4 holding rows worth $178,815,027.
- Accession
- 0001507673-24-000013
- Filer
- CIK 1507673
- Filed
- 2024-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 4 entries on the cover page, a total value of $178,815,027 stated on the cover page (in dollars after the unit check, H1), rows summing to $178,815,027 with VALUE read as dollars as filed, 13F file number 028-19261. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerLegorreta Pablo G.028-19630
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOHAVEN LTD | G1110E107 | COM | 2,936,507 | $101,926,158 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 980,392 | $53,117,639 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 3,846,154 | $23,769,232 | dollars as filed | |
| VIRACTA THERAPEUTICS INC | 92765F108 | COM | 3,700 | $1,998 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001507673-24-000013 | this filing | 2024-08-13 | acceptance time not in the bulk data set |